摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-fluorobenzo[b]thiophene | 1038780-99-2

中文名称
——
中文别名
——
英文名称
3-fluorobenzo[b]thiophene
英文别名
3-fluoro-1-benzothiophene
3-fluorobenzo[b]thiophene化学式
CAS
1038780-99-2
化学式
C8H5FS
mdl
——
分子量
152.192
InChiKey
FFHRKUDPEYUQSD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    28.2
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    3-fluorobenzo[b]thiophene盐酸 、 sodium carbonate 作用下, 以 乙醚乙酸乙酯三氟乙酸 为溶剂, 反应 0.37h, 生成 4-(3-fluorobenzo[b]thiophen-2-yl)-3,4-dihydroquinazoline hydrochloride
    参考文献:
    名称:
    In vivo phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents
    摘要:
    一种基于老鼠的检测方法(SmartCube)被用于一种新型抗精神病药物的筛选和首选优化。
    DOI:
    10.1039/c6md00128a
  • 作为产物:
    描述:
    3-溴苯并噻吩异丙基氯化镁lithium chlorideN-氟代双苯磺酰胺 作用下, 以 四氢呋喃 为溶剂, 反应 1.0h, 以29%的产率得到3-fluorobenzo[b]thiophene
    参考文献:
    名称:
    Analysis of the Concerted Metalation-Deprotonation Mechanism in Palladium-Catalyzed Direct Arylation Across a Broad Range of Aromatic Substrates
    摘要:
    The concerted metalation-deprotonation mechanism predicts relative reactivity and regioselectivity for a diverse set of arenes spanning the entire spectrum of known palladium-catalyzed direct arylation coupling partners. An analysis following an active strain model provides a more complete portrayal of the important arene/catalyst parameters leading to a successful coupling. The breadth of arenes whose reactivity can be predicted by the CMD mechanism indicates that it may be far more widespread than previously imagined.
    DOI:
    10.1021/ja802533u
点击查看最新优质反应信息

文献信息

  • Analysis of the Concerted Metalation-Deprotonation Mechanism in Palladium-Catalyzed Direct Arylation Across a Broad Range of Aromatic Substrates
    作者:Serge I. Gorelsky、David Lapointe、Keith Fagnou
    DOI:10.1021/ja802533u
    日期:2008.8.1
    The concerted metalation-deprotonation mechanism predicts relative reactivity and regioselectivity for a diverse set of arenes spanning the entire spectrum of known palladium-catalyzed direct arylation coupling partners. An analysis following an active strain model provides a more complete portrayal of the important arene/catalyst parameters leading to a successful coupling. The breadth of arenes whose reactivity can be predicted by the CMD mechanism indicates that it may be far more widespread than previously imagined.
  • THERAPEUTIC USE OF ACTIVATORS OF ZINC FINGER PROTEIN GLI3
    申请人:Universität Leipzig
    公开号:EP2806884A1
    公开(公告)日:2014-12-03
  • Therapeutic Use of Activators of Zinc Finger Protein GL13
    申请人:Universtität Leipzig
    公开号:US20140336111A1
    公开(公告)日:2014-11-13
    The present invention relates to the therapeutic use of activators of the zinc finger protein GLI3 in diseases that are associated with reduced Hedgehog signaling in hepatocytes, in particular Polycystic ovary syndrome, Steatosis hepatis, Steatohepatit is and/or Adipositas. The invention further relates to methods of treating an individual with said activator, a pharmaceutical composition comprising said activator and the use of said activator as food supplement.
  • US9540648B2
    申请人:——
    公开号:US9540648B2
    公开(公告)日:2017-01-10
  • [EN] THERAPEUTIC USE OF ACTIVATORS OF ZINC FINGER PROTEIN GLI3<br/>[FR] UTILISATION THÉRAPEUTIQUE D'ACTIVATEURS DE LA PROTÉINE À DOIGT DE ZINC GLI3
    申请人:UNIV LEIPZIG
    公开号:WO2013110749A1
    公开(公告)日:2013-08-01
    The present invention relates to the therapeutic use of activators of the zinc finger protein GLI3 in diseases that are associated with reduced Hedgehog signaling in hepatocytes, in particular Polycystic ovary syndrome,Steatosis hepatis, Steatohepatitis and/or Adipositas. The invention further relates to methods of treating an individual with said activator, a pharmaceutical composition comprising said activator and the use of said activator as food supplement.
查看更多

同类化合物